Sarah
McCrann

European Patent Attorney

Dublin Office Manchester Office

Electronics

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Sarah is a Senior Patent Attorney within our Electronics Group. Her experience includes drafting and prosecuting patent applications to assist her clients in a commercially-focussed manner. She has experience working with a wide range of technologies, for a wide variety of clients from start-ups and universities to large multinationals. Her clients include organisations operating in the areas of 3D printing, autonomous vehicles, consumer electronics, image processing and medical devices.

Qualifications

Patent Attorney

European
Irish


BENG

Bachelor of Electronic Engineering, University College Dublin, National University of Ireland

MENG

Masters in Telecommunications Engineering, Dublin City University

Conferences: 2021

October 4th 2021

IPBC Europe 2021

Attended

Event details

Conferences: 2019

September 12th 2019

Women in Tech Dublin

Speaker

Event details

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 19th May 2022

HGF Complete webinar: comparison of registered and unregistered design rights procedures before the EUIPO and UKIPO

HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.